---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020792"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:15:48.380649+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition postpones extension vote to May 22; enters non-redemption agreements to limit trust redemptions

## Summary
- Extraordinary general meeting further postponed to 2:00 p.m. ET on May 22, 2024 to vote on extending business combination deadline to Feb. 17, 2025.
- Shareholders may submit or withdraw redemption requests by 5:00 p.m. ET on May 20, 2024 (same day as filing).
- Sponsor SRIRAMA Associates enters non-redemption agreements; for every 150,000 non-redeemed shares, sponsor transfers 50,000 Class A shares to agreeing shareholders.
- Non-redemption agreements aim to increase funds remaining in trust account after the meeting.

## SEC filing metadata
- accession: 0001493152-24-020792
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224020792/0001493152-24-020792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224020792/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020792
- JSON: https://secwatch.observer/filing/0001493152-24-020792.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020792.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.